Skip to main content
Clinical Trials/NL-OMON27421
NL-OMON27421
Not yet recruiting
Not Applicable

A prospective, explorative cohort study to identify biomarkers of treatment response in oropharyngeal cancer.

Erasmus MC0 sites200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC
Enrollment
200
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Erasmus MC

Eligibility Criteria

Inclusion Criteria

  • To be eligible participating in this study, patients must meet all the following criteria:
  • Clinical diagnosis of squamous cell carcinoma of the oropharynx, with or without histological confirmation
  • In case of already histology\-confirmed oropharyngeal cancer \- primary tumor accessible for re\-sampling without general anaesthesia
  • Eligible for curative treatment with radiotherapy with or without the addition of systemic agents
  • Written informed consent obtained
  • Age \>\= 18 years

Exclusion Criteria

  • The following patients are not eligible for participation in this study:
  • Patients with histology\-confirmed oropharyngeal cancer, safely accessible for re\-sampling only under general anaesthesia
  • Patients currently under treatment for other malignant disease (unless basal cell carcinoma of the skin)
  • Previous radiotherapy in the head and neck area (with overlapping RT area)
  • Recurrent oropharyngeal cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials